These lab-produced alternatives weren't designed with recreational use in mind. From the nineties, John W. Huffman and a staff of fellow chemists at Clemson College established a lot of the initial formulation for artificial cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of